Stock listing
Genelux Corporation
Selected listing: GNLX · NASDAQ · USD · US
Genelux Corporation (NASDAQ:GNLX), Health Technology. Latest release Sep 9, 2026: Genelux Announces Publication of a Deep and Durable Response…
- Ticker
- NASDAQ:GNLX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Genelux Corporation
The company focuses on developing innovative therapies for cancer treatment. Genelux aims to advance its proprietary technologies to improve patient outcomes in oncology.
Latest news from Genelux Corporation
Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy
September 9, 2026
Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates
August 13, 2026
Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer
June 30, 2026
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
May 7, 2026
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 19, 2026